Media Hub

Oct 2018

New treatment may extend the survival rates of women with advanced breast cancer

A new clinical trial has suggested that by combining hormone therapy with a pioneering drug may extend the lives of some women with advanced breast cancer. The women who took part in the trial and received the drug palbociclib alongside hormone therapy lived for up to 40 months longer than those given hormone therapy alone.…

Read More